Birkett Bernard's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Aug 3, 2022
- Accession no.
- 0001562180-22-005857
- Filed
- Aug 3, 2022
- Trade date
- Aug 2, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.84M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Birkett BernardCIK 0001658001 | Officer (Sr VP, CFO & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2022 | Common Stock | SSaleDisposed | −9,359 | $340.50 | −$3,186,739.5 | 5,610 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −1,708 | $341.97 | −$584,084.76 | 3,902 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −2,007 | $342.59 | −$687,578.13 | 1,895 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −1,100 | $343.38 | −$377,718 | 795 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.